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Tumor cells invading three-dimensionalmatrices need
to remodel the extracellular matrix (ECM) in their path.
Many studies have focused on the role of extracellular
proteases [1, 2]; however, cells with amoeboid or
rounded morphologies are able to invade even when
these enzymes are inhibited [3, 4]. Here, we describe
the mechanism by which cells move through a dense
ECMwithout proteolysis. Amoeboid tumor cells gener-
ate sufficient actomyosin force to deform collagen fi-
bers and are able to push through the ECM. Force gen-
eration is elevated inmetastaticMTLn3E cells, and this
correlates with increased invasion and altered myosin
light chain (MLC)organization. Inmetastatic cells,MLC
is organized perpendicularly to the direction of move-
ment behind the invading edge. Both the organization
of MLC and force generation are dependent upon
ROCK function. We demonstrate that ROCK regulates
the phosphorylation of MLC just behind the invading
margin of the cell. Imaging of live tumors shows that
MLC isorganized in asimilarROCK-dependent fashion
in vivo and that inhibition of ROCK but not matrix-
metalloproteases reduces cancer cell motility in vivo.
Results and Discussion
Breast tumors are surrounded by a collagen-rich matrix
[5]; to mimic this environment, we overlaid cultured cells
with a collagen I gel [6]. After 24 hr, 20%–25% of MTLn3E
cells (A highly invasive subline of MTLn3 cells, MTLn3E
overexpresses the epidermal growth factor receptor
[7]) had invaded a distance of 20 mm or more (Figures
1A and 1B), whereas fewer than 5% of the nonmetastatic
parental MTC cells would invade 20 mm. Invading
MTLn3E cells had an amoeboid morphology (Figure 1B);
previous work has suggested that cells moving with this
morphology do not require extracellular proteases
[3, 4]. Figure 1C shows that treatment with GM6001,
which blocks a broad range of matrix-metalloproteases
(MMPs), did not inhibit the invasion of MTLn3E cells.
*Correspondence: erik.sahai@cancer.org.ukFurthermore, blockade of a broad range of serine and
cysteine proteases combined with MMP inhibition did
not block the invasion of MTLn3E cells (Figure 1C). We
confirmed the efficacy of this combination of protease
inhibitors by using gelatin zymography (see Figure S1
in the Supplemental Data available with this article on-
line, compare lanes 1 and 2 with 5 and 6). This also re-
vealed that MTLn3E cells only produce small amounts
of secreted proteases in comparison to HT1080 cells,
which normally use a protease-dependent form of inva-
sion [4] (Figure S1, compare lanes 1, 2, and 4).
To investigate how cells invaded in the absence of
proteolysis, we imaged the ECM as cells invaded it.
This revealed that collagen fibers were deformed as
cells invaded the ECM (Movie S1). We used DQA algo-
rithms [8] to accurately analyze changes in collagen im-
ages taken at 1-min intervals; representative images
from one such time series together with the output of
the DQA algorithms are shown in Figures 1D and 1E.
This revealed that the collagen in front of the invading
cell was pushed away from the cell. No consistent pat-
tern of deformation was observed at the rear of cells
(data not shown). In cases where the cell extended a pro-
trusion that was retracted without leading to translation
of the cell body, collagen was pulled toward the cell. By
measuring the degree of deformation caused by cali-
brated microneedles, we estimated that invading
MTLn3E cells exerted forces in the range of 10–20 nN.
This value is comparable with that measured for fish
keratinocytes [9, 10].
Deformation of collagen was observed by both con-
trol and GM6001-treated cells, indicating that MMP ac-
tivity is not required for MTLn3E cells to deform the col-
lagen matrix (Movies S1 and S2). We hypothesized that
the force needed to deform the collagen was generated
by productive actomyosin interactions [11]. Figure 1E
shows that blebbistatin, a nonmuscle myosin ATPase
inhibitor [12], dramatically reduced the extent of colla-
gen deformation. Actomyosin activity is regulated by
phosphorylation of MLC; therefore, we investigated
the effect of inhibiting kinases that can phosphorylate
MLC. Inhibition of MLC kinase (MLCK) reduced collagen
deformation but also inhibited the formation of cell pro-
trusions (data not shown); from this result, we could not
determine if MLCK function is specifically required for
force generation or for the initial extension of cell protru-
sions prior to force generation.
ROCK has also been shown to regulate myosin activity
by phosphorylating either the regulatory subunit of MLC
phosphatase or MLC directly (because of the high de-
gree of sequence similarity between ROCK1 and 2, we
refer to them generically as ROCK) [13, 14]. Inhibition
of ROCK by two different structurally unrelated ROCK in-
hibitors (Y27632 and H1152) significantly reduced colla-
gen deformation (Movie S3 and Figure 1E). Inhibition of
ROCK did not affect the low levels of protease activity
secreted by MTLn3E cells (Figure S1). Importantly, imag-
ing of the cells revealed that they were still able to extend
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1516Figure 1. Collagen Deformation and Invasion Is Protease Independent but ROCK Dependent
(A) The proportion of MTC and MTLn3E cells invading 20 mm or more in 24 hr is shown. The average of at least three independent experiments
with standard errors is shown; typically 200 cells were analyzed for each experimental condition.
(B) Representative three-dimensional reconstructions of MTLn3E cell invasion at either low magnification (upper panel) or high magnification
(lower panel) and stained with phalloidin to reveal F-actin; the arrow indicates an invading-actin-rich protrusion.
(C) The effect of 10 mM GM6001 or 10 mM GM6001 + 10 mM Aprotinin + 10 mg/ml Leupeptin on the ability of MTLn3E cells to invade 20 mm or more in
24 hr. The average of at least three independent experiments with standard errors is shown; typically 200 cells were analyzed for each experi-
mental condition.
(D) Three images of an MTLn3E cell (green) invading a collagen I matrix (red) are shown. Bottom-right image shows DQA analysis of collagen I
deformation by the cell shown in the other panels. Lines represent vectors of collagen deformation over 8 min; the direction of deformation is
running in a red to green direction.
(E) Quantification of the extent of collagen I deformation by MTC or MTLn3E cells from untreated, treated with 10 mM Y27632 and 5 mM H1152,
transfected with inhibitory ROCK mutant, treated with 12.5mM Blebbistatin, or treated with 10 mM GM6001. The average amount of collagen I
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1517protusions (Figure 2; data not shown); however, these
protrusions now extended over the surface of the matrix
and did not effectively penetrate into the matrix (com-
pare control cells in Figure 2Ci to inhibitor-treated cells
in Figures 2Ei–2Eii). We performed cell adhesion assays
to exclude the possibility that inhibition of ROCK altered
the amount of force exerted on the collagen by affecting
the cells’ ability to adhere to collagen. Figure S2A shows
that inhibition of ROCK did not affect the ability of
MTLn3E cells to adhere to collagen, although the organi-
zation of prominent adhesions at the front of the cell was
altered. We speculate that MLCK is required for protru-
sions to be efficiently formed but is not able to generate
sufficient force to deform the collagen matrix; in order for
this to occur, ROCK function is required.
If this ROCK-dependent force-mediated mechanism
of collagen remodeling is important for invasive and
metastatic potential, then invasive cells should generate
more force, and reducing force generation should pre-
vent invasion. Comparison of the behavior of metastatic
MTLn3E and nonmetastatic MTC cells revealed that
MTC cells generate significantly less force (Figure 1E).
This difference is not due to altered abilities to bind to
collagen I (Figure S2C). Next, we tested to see if the in-
vasion of MTLn3E cells could be prevented by reducing
their ability to deform the collagen matrix with ROCK in-
hibitors; Figure 1F shows that the invasion of MTLn3E
cells was significantly reduced by treatment with either
Y27632 or H1152. Similar results were obtained by
transfection of an inhibitory ROCK construct (data not
shown). These results establish that increased ROCK-
dependent force generation is required for the invasive
behavior of tumor cells.
To gain further insight into the regulation of MLC in the
invading MTLn3E cells, we performed time-lapse mi-
croscopy by using green fluorescent protein (GFP)-
labeled MLC. Figure 2A and Movie S4 show that MLC
was organized into bundles that were perpendicular to
the direction of movement just behind the F-actin-rich in-
vading edge. MLC was also found around the cortex at
the sides and rear of the cell. Reflectance imaging con-
firmed that the cell was moving within the collagen matrix
(data not shown). These data suggest that at the front of
the cell, MLC is bundled perpendicularly to the pushing
force generated by invading cells. To confirm this, we im-
aged MLC-mRFP (monomeric Red Fluorescent Protein)
in cells invading FITC collagen; Figure 2B shows that
the collagen is indeed pushed perpendicularly to the
MLC structures at the very front of the cell (area marked
‘‘fz’’). At the lateral margins (areas marked ‘‘lz’’), MLC
structures are less prominent but are now aligned with
the direction of cell movement and force generation;
this suggests that some force is applied along the acto-
myosin network at the sides of the cell.
We performed scanning electron microscopy (SEM) to
gain a more detailed insight into the cytoskeleton struc-
ture of invading cells. Figure 2C shows the actin cyto-
skeleton of an invading MTLn3E cell; we confirmed
that the filamentous structures observed were F-actinby treating cells with cytochalasin D to disrupt F-actin.
Figure S3 shows that this completely disrupted the
mesh in the cell cortex and significantly disrupted the fi-
bers in cell protrusions. Higher-magnification images
show F-actin extending in the direction of invasion
(marked with asterisks in Figure 2Ciii); this can also be
seen in F-actin staining of control cells in Figure 2A. Fur-
ther behind these structures is a very dense actin mesh-
work with frequent bundles that are perpendicular to the
direction of invasion (marked with arrowheads in Fig-
ures 2Cii–2Ciii); these thick bundles and dense actin
mesh are connected to the rest of the actin cortex and
are likely to be associated with MLC. Consistent with
this, inhibition of nonmuscle myosin ATPase activity
with blebbistatin [12] disrupted the dense actin mesh
and led to the appearance of flat ‘‘fan-like’’ arrays of
F-actin (marked with an arrow in Figure S3B).
In MTC cells, which generate less force than their met-
astatic counterparts, MLC was recruited to cell protru-
sions but was not bundled perpendicularly to the direc-
tion in which the protrusion was extending (Figure 2D
and Movie S5). Similarly, inhibition of ROCK in MTLn3E
cells did not prevent MLC from being recruited near
the invading edge of the cell but prevented it from being
aligned perpendicularly to the direction in which the cell
was extending a protrusion (Figure 2D and Movie S7).
Transfection of an inhibitory ROCK mutant also disrup-
ted the bundling of MLC (Figure 2D and Movie S8).
SEM analysis revealed that inhibition of ROCK function
caused cell protrusions to become longer and appear
flatter; in particular, the F-actin network just behind the
invading edge was much less dense and was oriented
in the same direction as the protrusion (Figures 2Ei–
2Eii). Because they are extending over the surface of
the matrix as opposed to invading into it, the protrusions
have a flatter appearance (see also the effect of blebbis-
tatin treatment in Figure S3C). In addition, we observed
that the actin meshwork throughout the cell cortex was
significantly less dense than in control cells (compare
Figures 2Civ and 2E), suggesting that ROCK may play
a role in regulating contractility of the actin network in
the cell cortex. In agreement with this, the localization
of MLC to the cell cortex in MTLn3E cells plated on top
of collagen I gel is significantly disrupted in cells treated
with either 5 mM H1152 or 10 mM Y27632. However, this is
not affected in cells treated with 25 mM ML-7 (Figure S4).
To test whether phosphorylation of MLC was required
for it to be aligned correctly, we used an MLC mutant with
both potential ROCK-regulated phosphorylation sites
mutated to alanine [15]; Figure 3A and Movie S9 show
that nonphosphorylated MLC can not be bundled in the
extending cell protrusion. Expression of this mutant
also reduced the invasion of MTLn3E cells (Figure 3B)
and modestly reduced collagen deformation (data not
shown). These data suggest that ROCK-dependent
phosphorylation is crucial for the correct organization of
MLC and force generation. Both recombinant ROCK1
and ROCK1 immune-precipitated from MTLn3E cells
could phosphorylate MLC on T18 and S19 in vitrodeformation is shown; we determined this by sampling 50–100 points within 50 mm of a cell and averaging 8–10 cells from two or three indepen-
dent experiments. The asterisk indicates p < 0.01 versus the control (Student’s T test).
(F) The effect of 10 mM Y72632 or 5 mM H1152 on the ability of MTLn3E cells to invade 20 mm or more in 24 hr. The average of at least three
independent experiments with standard errors is shown; typically 200 cells were analyzed for each experimental condition.
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1518Figure 2. Regulation of Actin and MLC Organization by ROCK in Invading MTLn3E Cells
(A) Images from a time-lapse series of GFP-MLC (green) in an MTLn3E cell moving in a collagen I matrix; the arrow indicates the direction of the
movement. Right-hand panel shows MLC organization in a fixed cell costained with phalloidin (red) to reveal F-actin.
(B) Images from a time-lapse series of mRFP-MLC (green) moving a FITC collagen I matrix (red, inset panels). Right-hand panel shows defor-
mation analysis of the cell shown in left-hand panels; fz highlights the area in front of the invading cell, and lz highlights the areas around the
side of the invading cell.
(C) SEM images showing F-actin in MTLn3E cells; (i) shows a control cell invading into gel (invading protrusion is labeled with a black arrow), (ii),
(iii), and (iv) show actin behind the invading edge, an invading edge, and cortical actin, respectively (white arrowheads indicate densely bundled
actin, and asterisks indicate actin-rich protrusions). The scale bar represents 1 micron.
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1519(Figure S4B), suggesting that ROCK may directly phos-
phorylate MLC in vivo. Next, we tested whether ROCK
did indeed regulate MLC phosphorylation in MTLn3E
cells. Figure 3C shows that treatment of MTLn3E cells
with H1152 to inhibit ROCK reduced the phosphorylation
of MLC2 (similar results were obtained with Y27632; data
not shown). Inhibition of MLCK alone had only a slight ef-
fect on MLC phosphorylation, whereas combined inhibi-
tion of ROCK and MLCK almost completely inhibited
MLC phosphorylation. These data support the idea that
ROCK and MLCK regulate distinct pools of MLC [16,
17]. Immunofluorescence of MTLn3E cells invading into
collagen revealed numerous spots of phosphorylated
MLC concentrated in the MLC bundle just behind the
F-actin-rich protusion (Figure 3D). Treatment with either
H1152 or Y27632 reduced the phosphorylation and orga-
nization of MLC near the F-actin-rich protrusion, whereas
inhibition of MLCK did not affect MLC phosphorylation or
organization in this zone. We obtained similar results by
using siRNA against MLCK. Imaging of cells treated with
ML-7 showed that these cells retained MLC bundles at
the cell cortex but did not efficiently extend protrusions
(data not shown). These data demonstrate that ROCK,
but not MLCK, regulates the phosphorylation of MLC in
a zone just behind the F-actin-rich protrusion; therefore,
we investigated whether ROCK protein was localized in
this zone. Figure 3E shows that ROCK1 is concentrated
within areas of the actin-rich protrusion and just behind
the protrusion, but we were unable to convincingly local-
ize ROCK2 or MLCK in this region (Figure 3E; data not
shown). Together, these data suggest a novel role for
ROCK1 in regulating MLC phosphorylation at the front
of the cell immediately subsequent to the formation of
the actin-rich protrusion. ROCK can also phosphorylate
LIMK; however, activation of LIMK antagonizes the mo-
tility of MTLn3 cells because active cofilin is required
for the directed movement of MTLn3 cells [18–20]. There-
fore, regulation of LIMK is not the crucial positive role of
ROCK in cell invasion.
We next asked if overexpression of ROCK1 or activa-
tion of ROCK function by expression of constitutively
active RhoA could promote the cortical bundles of
MLC in cells that normally lack these structures. Overex-
pression of ROCK1 in nonmetastatic MTC cells pro-
moted the cortical association of MLC but did not have
much effect on MLC organization in cell protrusions
(Figure 3F). Whereas constitutive activation of ROCK
by RhoAV14 caused the formation of MLC bundles all
around the cell cortex and antagonized the formation
of cell protrusions, this effect was reversed by blockade
of ROCK function with Y-27632 (Figure 3F). Together,
these data demonstrate that activation of ROCK func-
tion is sufficient to concentrate MLC at the cell cortex.
We also performed invasion assays to determine if alter-
ation of MLC organization was sufficient to confer inva-
sive behavior on noninvasive MTC cells. Neither overex-
pression of ROCK1 nor overexpression of RhoAV14 was
sufficient to drive the invasion of MTC cells. We specu-
late that this is because although activation of ROCKfunction was able alter the organization of MLC, many
other coordinated changes in the actin machinery are
needed to drive cell invasion [5].
To investigate the organization of the actomyosin net-
work in vivo, we generated MTLn3 cells that stably ex-
pressed MLC-GFP and injected them orthotopically
into the mammary fat-pad of mice. Western blot analysis
showed that the level of MLC-GFP expression in these
cells was similar to the level of endogenous MLC (data
not shown). Figure 4 shows that MLC was clearly local-
ized to the cortex of the majority of the cells. Live imaging
of the tumors revealed that MLC was recruited to ex-
tending cell protrusions and was often organized per-
pendicularly to the direction in which the protrusion
was being extended (Figure 4B and Movie S10). Consis-
tent with our in vitro analysis was our observation of
some collagen fibers’ localized deformation near dy-
namic cells at the tumor margins (Movie S10, mid-left
area); this observation indicates that significant amounts
of force are generated at tumor margins. In contrast,
MLC was not cortically organized in nonmetastatic
MTC tumors but was more diffuse with some occasional
fine bundles and spots of MLC (Figure 4A). No deforma-
tion of the collagen matrix was observed in time-lapse
movies of MTC tumors (data not shown).
To determine if ROCK regulates MLC in vivo, we in-
jected Y27632 intraperitoneally in tumor-bearing mice
and analyzed the phosphorylation and distribution of
MLC. Figure 4C shows that Y27632 reduced the phos-
phorylation of MLC in vivo. Intravital imaging of tumors
in Y27632-treated mice revealed that the localization of
MLC was dramatically altered; it was no longer orga-
nized in bundles around the cortex and behind the invad-
ing edge of the cell but was more diffusely localized in the
cytoplasm with occasional punctate patches around the
cell margin (Figure 4A). Next, we next analyzed time-
lapse movies to determine if inhibition of ROCK also af-
fected cell motility. Table 1 shows that Y27632 treatment
reduced the number of moving tumor MTLn3E cells by
70%; we obtained similar results by using A431 carci-
noma cells that also exhibit amoeboid cell motility
in vivo (Table 1; data not shown). There was also a
dramatic reduction in the number of rapidly moving non-
tumor cells in Y27632-treated animals (these cells are
visible as ‘‘dark shadows’’ moving among the fluores-
cent tumor cells).
MMP function was not required for tumor-cell inva-
sion in vitro (Figure 1C); to test this in vivo, we imaged
tumor-bearing mice injected with GM6001. Table 1
shows that injection of GM6001 only marginally reduced
the number of moving breast cancer cells and increased
the number of moving A431 cells. In contrast, the num-
ber of moving host cells was significantly reduced.
These results demonstrate that amoeboid tumor cell
motility in vivo is ROCK dependent but MMP indepen-
dent; this may partly account for the poor results of
MMP inhibitors in clinical trials [1].
We propose the following model of tumor-cell inva-
sion; initially, an F-actin-rich protrusion is extended;(D) Organization of MLC in MTC and MTLn3E cells; MTLn3E cells were treated with 10 mM Y27632 or cotransfected with an inhibitory ROCK1
construct where indicated (the arrow indicates the direction of protrusion extension).
(E) SEM images showing F-actin in MTLn3E cells; (i) and (ii) show protrusions of Y27632- and H1152-treated cells, respectively (white arrows in-
dicate the protrusion extending over the surface of the matrix). (iii) shows cortical actin of an H1152-treated cell. The scale bar represents 1 micron.
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1520Figure 3. ROCK Regulates MLC Phosphorylation Behind the Invading Edge
(A) Representative images from time-lapse series of GFP-MLC or GFP-MLC18A19A in MTLn3E cells in a collagen I matrix; the arrow indicates the
direction of the protrusion.
(B) The effect of transfection of MLC-TASA-GFP on the invasion of MTLn3E cells relative to control cells transfected with either GFP or YFP (the
average of three experiments is taken; the standard error is shown).
(C) The effect of 12.5 mM ML-7, 25 mM ML-7, or 5 mM H1152 on MLC2 phosphorylation in MTLn3E cells; one representative example of at least
three experiments is shown.
(D) Images show MLC2 and phosphoS19-MLC2 localization in untreated, 5 mM H1152, 10 mM Y72632, or 25 mM ML-7-treated MTLn3E cells and
control-irrelevant or MLCK siRNA-transfected cells; MLC is shown in red; phospho-MLC2 S19 is shown in green.
(E) Localization of ROCK1 and MLCK in invading MTLn3E cells is shown in green.
(F) Images show MLC2 localization in mock-transfected, ROCK-transfected, RhoAV14-transfected, or RhoAV14-transfected cells treated with
10 mM Y27632 in MTC cells. The scale bar represents 50 mm.this is ROCK independent. Subsequently, cell-ECM ad-
hesions form to connect the F-actin network to the
ECM; this is also ROCK independent but may be MLCKdependent [17]. ROCK1 localizes to the invading protru-
sion, promotes MLC phosphorylation, and enables pro-
ductive actomyosin interactions leading to the formation
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1521Figure 4. Organization of MLC In Vivo
(A) Metastatic MTLn3 or nonmetastatic MTC cells stably expressing MLC-GFP were injected into the mammary fat-pad of young adult female
mice and allowed to form a tumor. After 2–3 weeks, mice were injected with PBS (control) or Y27632; 40–200 min later, living tumors were imaged
with a multiphoton laser scanning microscope. MLC-GFP is shown in green; collagen second harmonic signal is shown in red. An asterisk de-
notes a cell shown in greater detail in (B).
(B) A series of time-lapse images of MLC-GFP localization in the cell marked with an asterisk in (A).
(C) Lysates of MTLn3E tumors from either mice injected with either PBS or Y27632 were Western blotted for phospho-S19 MLC2 or actin (loading
control).of a dense contracting actin mesh behind the invading
cell edge. This area may be analogous to the lamella de-
scribed in some two-dimensional studies [21]. The cell-
ECM adhesions are formed predominantly ahead of this
zone of actomyosin contractility; therefore, the net ef-
fect of the actomyosin contraction is to move the F-actin
meshwork of the cell cortex, and hence the whole cell
body, toward the adhesions at the front of the cell. As
a result of this contraction, actin and MLC are aligned
in bundles that are perpendicular to the direction of
movement; this is similar to the mechanism proposed
by Svitkina and Borisy for fish keratinocyte motility [22].
This region of dense bundled actin is continuous withthe cortical actin, and continued contraction around
the cell cortex will cause the cell body to move forward.
ROCK also regulates the localization of MLC to the cell
cortex and the density of the cortical actin meshwork.
Contraction of this network at the sides and rear of the
cell will generate hydrostatic pressure that may aid the
extension of the protrusion at the front of the cell. In 3D
environments, the surrounding ECM will provide resis-
tance to movement of the cell body toward the adhe-
sions at the front of the cell; however, MTLn3E cells
can overcome this by generating sufficient force to de-
form the collagen and couple movement of the invading
protrusion to the cell body. If cells are moving in an
Current Biology
1522environment such as on a two-dimensional substrate
that does not provide significant resistance to transloca-
tion of the cell body, then less force will be required and
ROCK activity may be dispensable [23].
The data presented here show that amoeboid tumor
cell motility is ROCK dependent but MMP independent.
Proteases are not needed because ROCK-dependent
regulation of MLC generates sufficient force to deform
the ECM and thereby enable cell movement.
Experimental Procedures
Cell Lines and Plasmids
MTLn3 cells were originally isolated by Welch and Nicolson [24];
MTLn3E cells are described in [7]. GFP-Zyxin was a gift from
F. Gertler described in [25]; GFP-MLC and GFP-MLC A18A19 were
gifts from M. Olson [15]; details of RhoAV14, ROCK1, and mRFP-
MLC are available on request. EF-ROCK1deltaNIA contains amino
acids 945–1355 of human ROCK1 with I1009 mutated to A. Cells
were transfected with Fugene-6 in accordance with the manufac-
turer’s instructions. Dharmacon SMARTpool siRNA M-087114-00-
0010 was used to target MLCK; cells were transfected with Oligofect-
amine in accordance with the manufacturer’s instructions.
Antibodies and Inhibitors
Antibodies used were as follows: phosho-S19 MLC2 (Cell Signaling
#3671), phosho-T18S19 MLC2 (Cell Signaling #3674), MLCK (Sigma
M7905), ROCK1 (sc-6056 Santa Cruz), b-tubulin (Sigma T 7816), and
Zyxin (Synaptic Systems). Inhibitors used were as follows: Aprotinin
(Sigma A1153), Blebbistatin (Calbiochem #203391), GM6001 (Cal-
biochem #364205), H1152 (Calbiochem #555550), Leupeptin (Sigma
L 2884), and Y27632 (Tocris #1254).
Kinase Assays
Kinase assays were performed essentially as described in [26]. Re-
combinant ROCK1 was purchased from Upstate (cat #14-601).
ROCK1 was immunoprecipitated with goat anti-ROCK1 (sc-6056
Santa Cruz). Recombinant MLC2 was prepared in BL21 E. coli (de-
tails available on request). Phosphorylation status was analyzed
by Western blot with phosho-S19 MLC2.
Invasion Assays and Imaging
Collagen I invasion assays were performed as described by Gos-
wami et al. [6] with 4–4.5 mg/ml collagen I (BD Bioscience catalog
#354249). For immunofluorescence and time-lapse studies, cells
were plated on top of a 4–4.5 mg/ml collagen I gel. For gel deforma-
tion analysis, 0.1 mg/ml FITC collagen (Sigma C4361) was added to
the collagen I gel. For immunofluorescence studies, cells were fixed
in 4% paraformaldehyde and permeabilized with 0.2% Triton X-100
before they were rinsed with phosphate Buffered Saline (PBS) and
Table 1. Quantification of the Number of Cell-Movement Events
in Orthotopic Breast MTLn3 Tumors or Subcutaneous SCC A431
Tumors in Control, GM6001-Treated or Y27632-Treated Animals
Control +GM6001 +Y27632






Number of SCC cells
moving (events/mm2/hr)
65 143 22
Tumor cells were identified on the basis of fluorescent-protein ex-
pression; nontumor cells in breast MTLn3 tumors were visible as
‘‘shadows’’ moving among labeled tumor cells. Data are taken
from imaging four tumors at four different sites in each tumor for
each experimental condition; to enable a comparison, we divided
the total number of events observed by the area of tumor imaged
and the length of time the tumor was imaged.blocked with 5% BSA. Primary antibodies were diluted 1:50, and sec-
ondary antibodies from Molecular Probes were 1:200, and TRITC-
phalloidin (Sigma P1951) was used at 250 mg/ml.
Gelatin Zymography
HT1080 or MTLn3E cells were cultured for 18 hr in serum-free media
supplemented with 2.5% chemically defined lipid concentrate
(GIBCO 11905-031) and, where indicated, 5 mM H1152 or 10 mM
GM6001 + 10 mM Aprotinin + 10 mg/ml Leupeptin before the media
was removed and put through a 0.45 mm filter. After the addition of
a 203 concentration of the protein content with Amicon Ultra
30,000 MWCO spin columns (Millipore), an equal volume of nonre-
ducing SDS-PAGE buffer was added to the cells. Samples were
analyzed with 10% acrylamide nonreducing SDS-PAGE containing
1.5 mg/ml gelatin before zymography was carried out as described
in [27].
Adhesion Assays
Adhesion to collagen I was determined as described in [28] with
Chemicon-coated strips (cat. no. ECM104).
SEM
Cells were plated on top of Matrigel (BD Bioscience 354234) in the
presence or absence of inhibitors; after 16 hr, cells were extracted
and fixed according to the method of Bailly et al. [29]. In brief, cells
were rinsed twice in Buffer C + 1% BSA + 0.25% Triton X-100 + 5 uM
phalloidin for 1 min before fixation in cytoskeleton stabilizing solu-
tion + 0.5% gluteraldehyde + 0.25% Triton X100 + 5 mM phalloidin.
Samples were critical-point dried before sputter coating; analysis
was performed with a JOEL FESEM 6700 (details available on
request).
In Vivo Imaging
One million MTLn3 cells stably expressing MLC-GFP were injected
under the nipple of 5 to 6-week-old nude mice. A431-GFP cells
were injected subcutaneously. After 16–24 days, mice were anaes-
thetized with isofluorane, and a skin flap was cut to expose the tu-
mor before the mouse was positioned on an LSM510 laser scanning
microscope connected to a Chameleon Coherent Ti-Sapphire laser
tuned to 850 nm [30]. Anesthesia was maintained while time-lapse
movies were made of the tumors. Thirty to forty minutes before im-
aging, mice were injected intraperitoneally with 100 ml PBS, 1 mg of
Y72632 dissolved in 100 ml PBS, or 0.75 mg of GM6001 dissolved in
100ml PBS + 12.5% DMSO (GM6001 was also injected 16 hr before
imaging).
Supplemental Data
Supplemental Data include four figures and ten movies and can be
found with this article online at http://www.current-biology.com/
cgi/content/full/16/15/1515/DC1/.
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